Zapping liver tumors: new device trial seeks to boost cancer fight
NCT ID NCT03203525
Summary
This early-stage study is testing the safety and best dose of combining standard chemotherapy drugs with a portable device that uses electrical fields to try to stop tumor growth. It is for patients whose cancer has spread to the liver and has not responded to other treatments. The main goal is to see if this combination is safe and tolerable, while also looking for early signs that it might help control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.